Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; gleevec) in chronic-phase chronic myelogenous leukemia. (Q44285235)
Jump to navigation
Jump to search
scientific article published in January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; gleevec) in chronic-phase chronic myelogenous leukemia. |
scientific article published in January 2003 |
Statements
Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; gleevec) in chronic-phase chronic myelogenous leukemia (English)
Hagop M Kantarjian
Stefan Faderl
2 references
Jorge Cortes
2 references
Susan O'Brien
1 reference
Mary Beth Rios
2 references
Francis Giles
1 reference
Francis Giles
Jianqin Shan
Moshe Talpaz
Susan O'Brien
Ralph Arlinghaus